NCT02420782View on ClinicalTrials.gov

First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology

PHASE1CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

ASP6282

oral

DRUG

Itraconazole

oral

DRUG

Pilocarpine

oral

DRUG

Placebo

oral

DRUG

Midazolam

oral

Trial Locations (2)

14050

Site DE49001, Berlin

HA1 3UJ

Site GB44001, Harrow

All Listed Sponsors

lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT02420782 - First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology | Biotech Hunter | Biotech Hunter